The CommonHealth

Drs. Armand Sprecher and Adi Nadimpalli, MSF, directed on-the-ground operations in Ituri and North Kivu provinces in recent months. They unpack why no one should feel comfortable with a runaway Ebola outbreak in eastern DRC that continues to outstrip the response. Reassuring statements from other sources notwithstanding.

Megan Ranney, Dean of the Yale School of Public Health for the past three years plus, reflects on the 25th anniversary of 9/11. And what she has learned and the innovations she has spearheaded leading Yale in an uncertain, highly volatile moment. "The slow destruction of trust is perhaps the greatest challenge."  We will not see any change so long as "we haven't done anything about it."  

Zipline has drawn attention for its record of success delivering life-saving medical products by drone through its expanding network across key African partner countries, including Cote d’Ivoire, Ghana, Nigeria, and Rwanda. Its on-demand supply chain approach has expanded access to vaccines, emergency blood products, and other treatments, especially in hard-to-reach rural areas, contributing to dramatic gains in reaching zero-dose children, treating severe malaria, and reducing maternal mortality. The company has also been a subject of interest following its $150 million award from the U.S. Department of State, as a model for the innovative, public-private partnerships that are a stated priority of the America First Global Health Strategy, and its new approach to commercial diplomacy. Please join the CSIS Bipartisan Alliance for Global Health Security for a discussion reflecting on Zipline’s work to expand its delivery network, the evolution of its partnership with African partner governments and the U.S. State Department, and what the company has learned about the potential for emerging technologies to increase health access and outcomes. J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center will moderate the discussion with Caitlin Burton, CEO of Zipline's International Business.

Monisha Ashok, Director of Health Investments, U.S. International Development Finance Corporation (DFC) lays out how health now figures in DFC's strategy following the late 2025 Congressional reauthorization that increased its investment cap by more than threefold to $205 billion with much greater flexibilities, including equity investments and engagement in high-income countries. Under the DFC "strategy refresh," health has been elevated as a priority, with special emphasis on supply chain resilience and biosecurity. There is enormous market concentration of active pharmaceutical ingredients (APIs) and key starting materials (KSM) in China, where investments in near- or friend-shores production are essential to create more diverse and resilient supply chains. Biosecurity encompasses medical countermeasures (vaccines, therapies, tests); labs and advanced diagnostics; and bio surveillance. Increasingly, DFC is drawn to support the many signed MOUs with partner countries, under the America First Global Health Strategy. During the General Assembly in New York the week of September 21, DFC will join a panel on the first anniversary of AFGHA and a roundtable on financing pandemic preparedness and response.  

Hayley Severance, Deputy Vice President, Global Biological Policy and Programs, Nuclear Threat Initiative (NTI), walks us through the newly launched Africa Health Security Index (AHSI): its origin and purpose; its key African and other partners; what it reveals about significant progress in Africa since 2021 (surveillance, countermeasures) and what it reveals about glaring problems (biosafety/biosecurity, finance). The challenge now is to get the AHSI in front of senior African decision makers, and to engage with the Trump administration, among others, at this moment when the Bundibugyo Ebola outbreak is raging.